David B. Nash, MD, MBA is the Founding Dean of the Jefferson School of Population Health where he is the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy. He is a board certified internist and is internationally recognized for his work in outcomes management, medical staff development and quality-of-care. He has authored more than 100 articles in major journals, edited 22 books, and is editor-in-chief of four major national journals.

Stephen Klasko is CEO of Thomas Jefferson University and CEO of TJUH System after serving as CEO of USF Health and dean of the college of medicine at University of South Florida.. A board certified OB-GYN, he is bridging the art and science of medicine and healthcare information technology through an entrepreneurial-academic model. After receiving his M.D, and completing his obstetrics and gynecology residency, he completed his M.B.A. at the Wharton School of Business, University of Pennsylvania.

He has been on the boards of several national non-profit hospital systems and is currently on the corporate board of Teleflex (TFX: NYSE) a global medical device company. He has written extensively on the need to change the "DNA of healthcare" by transforming the selection and education of health professionals. To that end, he has received over $4 million in grants researching the biases affecting physicians' willingness to accept change. He has written over 400 peer reviewed articles and several books including "The Phantom Stethoscope" and "Mamas Don't Let Your Babies Grow Up to Be OB-GYNs"

Bruce Broussard was appointed by Humana's Board of Directors as President and Chief Executive Officer effective January 1, 2013, completing a year-long transition plan to the CEO role.

Under Bruce's leadership, Humana is creating an integrated care delivery model that is expected to drive lower costs, enhanced quality, improved outcomes and a better member experience. With its holistic approach to members' health, Humana is well-positioned to fulfill its aspiration to help people achieve lifelong well-being.

Bruce joined Humana as President in December 2011. He brings to Humana a wide range of executive leadership experience in publicly traded and private organizations within a variety of healthcare sectors, including oncology, pharmaceuticals, assisted living/senior housing, home care, physician practice management, surgical centers, and dental networks.

Kevin Carr, MD is a seasoned clinical transformation and HIT professional. He has significant experience in medical informatics, clinical process improvement, 100% provider adoption of clinical information systems including CPOE, HIE strategy/ operations, and the management of clinical content as a part of advanced clinical information systems. Deep experience includes guiding the development of Health Information Exchanges in four states and the United Kingdom (London Programme for Information Technology). Additionally, he has assisted with electronic medical records implementations in two additional states (outside of those in which he provided HIE assistance).

Sid Kosaraju is the Global Managing Director of Accenture Health Management Services. His responsibilities include driving global strategy, differentiated population health offerings and sustained financial growth for this fast growing Accenture business.

Mr. Kosaraju joined Accenture after nearly two decades of entrepreneurial leadership at various healthcare companies. Previously, he served as an early start-up member for the online pharmacy PlanetRx, helping the company achieve rapid growth and an initial stock offering on the NASDAQ stock market. Subsequently, he co-founded the global business process outsourcing (BPO) company 24/7 Customer, helping the firm scale to more than 3,000 employees and obtain profitability.

Randy Scott, Ph.D. is co-founder, chairman and CEO of Invitae Corporation, a privately owned company focused on bringing comprehensive genetic information into routine medical practice. Prior to starting Invitae, Dr. Scott founded Genomic Health in 2000 and led the company as CEO for nine years with a focus on improving the quality of treatment decisions for patients with cancer. Dr. Scott has played a role in founding several successful biotech companies in addition to Genomic Health Inc., including Incyte, a genomic information company. Dr. Scott has authored over 40 scientific publications, obtained 20 patents, and has been the recipient of numerous awards.

Lesli is the Director of Oracle Healthcare Business Intelligence for Perficient. She is a clinical measurement advocate with 18 years of healthcare analytics and business intelligence experience covering for-profit, state, academic and federal healthcare including ambulatory clinic management, comparative effectiveness evaluation, evidence-based medicine, population health and clinical data warehousing. Prior to joining Perficient, Lesli championed activities with Tenet, The University of Texas MD Anderson Cancer Center, The University of Virginia Medical Center, and the US Navy.

Randy Scott, Ph.D. is co-founder, chairman and CEO of Invitae Corporation, a privately owned company focused on bringing comprehensive genetic information into routine medical practice. Prior to starting Invitae, Dr. Scott founded Genomic Health in 2000 and led the company as CEO for nine years with a focus on improving the quality of treatment decisions for patients with cancer. Dr. Scott has played a role in founding several successful biotech companies in addition to Genomic Health Inc., including Incyte, a genomic information company. Dr. Scott has authored over 40 scientific publications, obtained 20 patents, and has been the recipient of numerous awards.

Patrick has co-founded a dozen life science organizations in the last 20 years and has been called the godfather of applied genomics and personalized medicine.

Patrick F. Terry is a social entrepreneur who has founded a series of innovative philanthropic, research, and commercial organizations based on the life sciences, applied technology, and social-network theory. In 2000, he and a group of prominent leaders in the fields of genomics, bioinformatics and biotechnology founded Genomic Health, Inc. (NASDAQ: GHDX), a pioneering personalized medicine company based in California. His perspective is forged from personal and family experiences with genetic disease, cancer, and extensive work in the patient advocacy community. He is a lay person – his scientific, technical, and medical knowledge is all self-taught. He has published dozens of peer-reviewed scientific papers, articles, and book chapters in the field of genetics, personalized medicine, and biomedical research. Some of his activities have included leadership positions on numerous trade associations, professional societies, corporate boards, journal editorial boards, and a number of international advisory bodies. He has experience doing hands-on bench science, coordinating human genetics research, conducting clinical research, and managing multiple life science patents. He has been involved with over two hundred personalized medicine companies in shepherding multiple products through commercial development to clinical delivery in North and South America, Europe, South Africa, Israel, Japan, and China. He has received many honors and awards in the business and scientific communities internationally. He has dedicated his career to helping people and advancing a patient-centered perspective in research, product development, and translational medicine. He is active internationally with strategic management and financing of precision medicine companies for numerous indications and technologies.

Dr. Steven Tucker in a medical oncologist and general internist living and practicing in Singapore since 2006. Previously a member of the clinical faculty at the UCLA School of Medicine, Dr. Tucker now manages a global practice with patients across the world. A digital health enthusiast, Dr. Tucker embraces innovation, technology, and communication to transform healthcare. He passionately believes we are entering an era of proactive wellness and truly individualised care.

Christopher Olivia, MD leads Continuum into the future of healthcare as the organization develops its ambulatory care service model. With nearly 20 years of experience in healthcare services and health information technology, Dr. Olivia has served as Managing Director of Navigant and as Senior Vice President for Strategic Planning and New Venture Development at Highmark/West Penn Allegheny. Dr. Olivia led the growth of Cooper Health System as President and CEO, and also helped conceive its medical school. Dr. Olivia was recognized as one of the nation's 50 most powerful physician executives in 2010 by Modern Healthcare and Modern Physician magazines.

As Chief Medical Officer for Continuum Health Alliance, Dr. Renzi designs, implements and oversees the company's Population Health Management Service, including programs involving patient-centered medical care, information technology and shared savings reimbursement models. Certified by the American Board of Internal Medicine and a Fellow of the American College of Physicians, Dr. Renzi joined Advocare Heights Primary Care, where he now serves as vice president. His clinical interests include adolescent medicine, psychiatry, asthma, and dermatologic procedures.

Diane Weiner is a senior executive, certified healthcare consultant with over 30 years of experience. She founded and operated a leading employee benefit consulting firm in the Southeast, providing services to large employers. Her company, Benefit Concepts, Inc., was acquired after 20 successful years in business. Diane began her career with BCBS of Illinois, and then at Johnson & Higgins national consulting firm. As an executive and entrepreneur, Diane has a proven track record in operations, consulting, business development, and client relationship. She excels at identifying and implementing innovative solutions that address complex problems. Diane holds a B.S. in Human Resources from Indiana University, Bloomington.

Dr. Robert (Jay) Widmer is currently in the second year of an ABIM-sponsored clinical investigator program affiliated with Cardiovascular Diseases Fellowship. He achieved his undergraduate work at Southwestern University in Georgetown, TX and his combined MD/PhD at Texas A&M Health Sciences Center in 2009. He was then accepted to the prestigious clinical research track at Mayo in Rochester, MN. Additionally, Dr. Widmer is completing the selective Mayo Clinic Physician Scientists Clinical Research Certificate program. He completed his Internal Medicine Training in June of 2012, is now board certified, and will re-engage his clinical Cardiology training in July of 2014 with plans to pursue training in interventional cardiology.

Tom Boosinger is the founder and CEO of Synaptic Advisory Partners. Tom has over 18 years of experience working with leading organizations to develop cloud-based care and relationship management technologies. Over the course of his tenure, Tom has led countless successful software development and integration projects which have directly impacted key business objectives of his clients. At Synaptic, Tom has worked with some of world's most prominent and progressive healthcare leaders to develop Synapse, an award-winning, cloud based care and population health management platform that helps organizations coordinate care, improve health outcomes, increase staff productivity, and collaborate across the care continuum.

Scott W. Dahl is Director, Business Development for Healthy Communities Institute (HCI) and currently resides in Atlanta, Georgia. Prior to HCI, Scott served as the Vice President for CRM Healthcare leading continuing medical education development; the Director, Clinical Improvement for VHA Inc.; and as Manager, Market Development for Kimberly-Clark Healthcare overseeing international expansion and new product development. Scott has a Masters degree from the University of Houston and a Bachelor of Science degree from the University of Texas at Austin.

Harry Leider, MD, MBA has over 20 years experience as a physician executive in a variety of innovative healthcare organizations. He currently is the Chief Medical Officer and Group Vice President of Walgreens, and in this role is responsible for ensuring enterprise-wide health and wellness service offerings and outcomes that provide customer value and improve patient lives. Prior to joining Walgreens, Dr. Leider was Chief Medical Officer and Senior Vice President of Ameritox. In addition to his extensive background in disease management, and healthcare consulting, Dr Leider has broad experience in managed care. He served as the Chief Medical Officer for HealthNet, a large hospital-owned managed care organization, and was a physician executive at Harvard Community Health Plan.

Tamara Vehige Calise, DrPH, M.Ed is a Senior Research Scientist at JSI. She has over 16 years of public health experience at the local, state, and federal government levels, as well as in academia. Dr. Calise's interests are in obesity and chronic disease prevention, as well as eliminating health disparities across these outcomes to improve population health. Her experience includes conducting research to better understand how community environments and policies influence behavior, and collaborating with diverse partners at the state and local levels to apply the science to create physical and social systems that support population health.

Dr. Skoufalos is Associate Dean for Professional Development at the Jefferson School of Population Health. In addition to leading the school's professional development division, she oversees JSPH's external communications, including the school's affiliated peer-reviewed journals and newsletters, the website, blog and social media.

Dr. Skoufalos has edited several books and has authored articles related to medical education and quality improvement. She is an Associate Editor for American Journal of Medical Quality, and serves on the editorial boards of Population Health Management, Population Health Insider and American Health and Drug Benefits.

A career educator, Dr. Skoufalos received her doctorate in Organizational Leadership and a Master's degree in Education Management and Administration from Nova Southeastern University, and her bachelor's in Education from Temple University.

Neil Goldfarb is President and CEO of the Greater Philadelphia Business Coalition on Health, established in the fall of 2011 with the mission of developing best practices for maintaining a healthy workforce, and ensuring that when healthcare is needed it is safe, high-quality, accessible and affordable. Mr. Goldfarb has over 30 years of healthcare research and management experience. As Associate Dean for Research in the Jefferson School of Population Health, he was responsible for developing and carrying out the School's research agenda, focused on healthcare quality and value. Concurrently, Mr. Goldfarb served as Director of Ambulatory Care Performance Improvement for the Jefferson faculty practice plan.

Chris is the Director of Payer and Pharmacy Alliances with Sanofi's Center for Chronic Disease Prevention & Wellness. Her responsibilities include collaborating with employers; health plans; integrated, at-risk delivery networks and pharmacies around efforts to prevent chronic disease and seek value in health care delivery and spend. She has over 20 years of experience in the health care marketplace and the field of Human Resources. Chris graduated from Michigan State University with a BA in Employment Relations and resides in Grand Rapids, Michigan.

Harry Leider, MD, MBA has over 20 years experience as a physician executive in a variety of innovative healthcare organizations. He currently is the Chief Medical Officer and Group Vice President of Walgreens, and in this role is responsible for ensuring enterprise-wide health and wellness service offerings and outcomes that provide customer value and improve patient lives. Prior to joining Walgreens, Dr. Leider was Chief Medical Officer and Senior Vice President of Ameritox. In addition to his extensive background in disease management, and healthcare consulting, Dr Leider has broad experience in managed care. He served as the Chief Medical Officer for HealthNet, a large hospital-owned managed care organization, and was a physician executive at Harvard Community Health Plan.

Ricky plays a central role within Sg2's Center for Strategic Planning, providing thought leadership on key strategic issues facing hospitals and health systems. His work supports Sg2's intelligence suite, which includes publications, conferences and educational offerings.

Ricky was also a member of Sg2's consulting practice for five years, where he led strategic planning engagements.

Before joining Sg2, Ricky served as a senior auditor with Houston Methodist where he managed projects designed to improve business and clinical operations.

Ricky received his MBA from the Kellogg School of Management at Northwestern University and a BBA from the University of Texas at Austin.

As the senior leader of the Sg2 Center for Performance Strategy, Joan specializes in working with executive leadership teams to improve growth and performance across the continuum. The Center for Performance Strategy works from the perspective that an organization's future success depends on its ability to demonstrate strong performance in clinical effectiveness, operational efficiency, prudent margin management and growth. Joan also provides thought leadership in the areas of future-focused facility planning and strategic operations in community and post-acute care services. As the company's chief nursing officer, Joan leads the transformation of nursing practice and operations across the care continuum.

Internationally-recognized strategy consultant Rita E. Numerof, Ph.D. is President and co-founder of Numerof & Associates, Inc. (NAI). Working globally across the healthcare industry with clients in delivery, pharmaceuticals, medical devices, payers, and policy, NAI brings significant experience with current and alternative business models within the healthcare industry, ensuring clinical and financial integration and managing variability in cost and quality. NAI has helped clients with such diverse issues as accountable care, bundled pricing, and consumer engagement - paving the way for population health management. Rita has also authored five books, including Healthcare at a Turning Point: A Roadmap for Change.

Ron Loeppke, MD, MPH, FACOEM, FACPM is Vice-Chairman of U.S. Preventive Medicine (USPM), and serves as co-Chair of the company's International Advisory Board. Dr. Loeppke has over 30 years of experience in healthcare and was the Founder, CEO and President of the Health and Productivity Corporation of America (HPCA). HPCA was acquired by CorSolutions where Dr. Loeppke became Chief Health Officer. CorSolutions was then acquired by Matria (a publicly traded healthcare company) where he became Chief Strategy Officer. Matria was then acquired by Alere (also a publicly traded healthcare company). He is Board Certified in Preventive Medicine and Fellowship trained in Occupational Medicine. Dr. Loeppke is President of American College of Occupational and Environmental Medicine (ACOEM). He is also Chairman of the Diabetes at Work group (http://www.diabetesatwork.org/ as part of the Center for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) National Diabetes Education Program (http://ndep.nih.gov/).

Stephanie S. McCutcheon is an Innovation/Transformation Advisor for health systems evolving from Integrated Delivery Systems to Population Health Management Systems. Her services focus on organizational ability to accelerate the pace of change and create sustainability working with CEOs and their teams. An Innovation/Transformation Model has been developed and provides an approach and methodology to design, implement, and operationalize a Value-Based Care System to accomplish the Triple Aim plus Physician/Clinician/Staff satisfaction. This has been piloted and implemented in an academic medical center, a regional health system, and a design has been set for a rural health care delivery system. Stephanie has been a health system CEO and COO for multi-state healthcare systems.

Dan Witters serves as Research Director of the Gallup-Healthways Well-Being Index. As a consultant and analyst for Gallup, Dan has used his expertise in survey design, methodology, analysis, business outcomes modeling, report writing, and presenting results to help leaders better understand their company's marketplace, customers, and employees. He has played an important role as an advisor and researcher to Gallup clients, creating effective strategies that enhance a business' overall health and strength through enhanced engagement and well-being. Dan frequently presents at major conferences and summits, and his insights from this research appear regularly on Gallup.com and in the media, including appearances on "CBS Sunday Morning," CNBC, HuffPost Live, and NPR.